Steve Remondi

Steve Remondi is the CEO and founder of Xsphera Biosciences. Steve has over 25 years of experience in the healthcare and technology industries.

Steve co-founded Exa Corporation in 1992 and served as its CEO for over 25 years. Exa is a leading provider of simulation software and services for the automotive, aerospace, and manufacturing industries. Under Steve’s leadership, Exa grew from a startup to a publicly traded company with over 500 employees and $100 million in annual revenue.

In 2018, Steve left Exa to pursue their next venture, Xsphera Biosciences. Xsphera is a healthcare startup that is developing a new class of drugs that target the body’s immune system.

Steve is a graduate of Tufts University and the Tufts University Gordon Institute. Steve also has an MBA from the Wharton School of Business.

Steve Remondi received a Bachelor of Science in Electrical and Electronics Engineering from Tufts University and a Master of Business Administration in Finance and General from Bentley University.

Some individuals on their team include Mike Perricone - CSO, Co-Founder, David Barbie - SAB, Principal Founder, and Amir Aref - VP, Translational Sciences.